vs

Side-by-side financial comparison of CHICAGO RIVET & MACHINE CO (CVR) and Sensus Healthcare, Inc. (SRTS). Click either name above to swap in a different company.

CHICAGO RIVET & MACHINE CO is the larger business by last-quarter revenue ($6.0M vs $4.9M, roughly 1.2× Sensus Healthcare, Inc.). CHICAGO RIVET & MACHINE CO runs the higher net margin — -19.3% vs -64.1%, a 44.8% gap on every dollar of revenue. On growth, CHICAGO RIVET & MACHINE CO posted the faster year-over-year revenue change (45.9% vs -62.2%). CHICAGO RIVET & MACHINE CO produced more free cash flow last quarter ($24.3K vs $-2.4M). Over the past eight quarters, CHICAGO RIVET & MACHINE CO's revenue compounded faster (-12.7% CAGR vs -31.9%).

Chicago Pneumatic, also known as "CP", is an industrial manufacturer providing power tools, air compressors, generators, light towers and hydraulic equipment. Products are sold in more than 150 countries through a worldwide distribution network. CP is active on markets such as tools for industrial production, vehicle service, maintenance repair operation for mining, construction, infrastructure equipment.

Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.

CVR vs SRTS — Head-to-Head

Bigger by revenue
CVR
CVR
1.2× larger
CVR
$6.0M
$4.9M
SRTS
Growing faster (revenue YoY)
CVR
CVR
+108.1% gap
CVR
45.9%
-62.2%
SRTS
Higher net margin
CVR
CVR
44.8% more per $
CVR
-19.3%
-64.1%
SRTS
More free cash flow
CVR
CVR
$2.4M more FCF
CVR
$24.3K
$-2.4M
SRTS
Faster 2-yr revenue CAGR
CVR
CVR
Annualised
CVR
-12.7%
-31.9%
SRTS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CVR
CVR
SRTS
SRTS
Revenue
$6.0M
$4.9M
Net Profit
$-1.2M
$-3.2M
Gross Margin
2.7%
38.4%
Operating Margin
-15.3%
-63.8%
Net Margin
-19.3%
-64.1%
Revenue YoY
45.9%
-62.2%
Net Profit YoY
68.0%
-304.9%
EPS (diluted)
$-0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVR
CVR
SRTS
SRTS
Q4 25
$6.0M
$4.9M
Q3 25
$7.4M
$6.9M
Q2 25
$7.3M
$7.3M
Q1 25
$7.2M
$8.3M
Q4 24
$4.1M
$13.1M
Q3 24
$7.0M
$8.8M
Q2 24
$8.1M
$9.2M
Q1 24
$7.9M
$10.7M
Net Profit
CVR
CVR
SRTS
SRTS
Q4 25
$-1.2M
$-3.2M
Q3 25
$67.6K
$-943.0K
Q2 25
$-395.0K
$-1.0M
Q1 25
$401.0K
$-2.6M
Q4 24
$-3.6M
$1.5M
Q3 24
$-1.4M
$1.2M
Q2 24
$142.1K
$1.6M
Q1 24
$-698.0K
$2.3M
Gross Margin
CVR
CVR
SRTS
SRTS
Q4 25
2.7%
38.4%
Q3 25
18.1%
39.4%
Q2 25
13.4%
39.7%
Q1 25
22.9%
52.2%
Q4 24
-43.7%
54.4%
Q3 24
10.0%
59.3%
Q2 24
17.6%
58.7%
Q1 24
9.5%
62.5%
Operating Margin
CVR
CVR
SRTS
SRTS
Q4 25
-15.3%
-63.8%
Q3 25
0.9%
-37.3%
Q2 25
-5.7%
-26.6%
Q1 25
1.0%
-31.7%
Q4 24
-86.4%
13.2%
Q3 24
-11.8%
16.9%
Q2 24
1.3%
21.5%
Q1 24
-11.5%
27.1%
Net Margin
CVR
CVR
SRTS
SRTS
Q4 25
-19.3%
-64.1%
Q3 25
0.9%
-13.7%
Q2 25
-5.4%
-14.2%
Q1 25
5.5%
-30.8%
Q4 24
-88.0%
11.8%
Q3 24
-20.8%
13.7%
Q2 24
1.8%
17.4%
Q1 24
-8.9%
21.3%
EPS (diluted)
CVR
CVR
SRTS
SRTS
Q4 25
$-0.19
Q3 25
$-0.06
Q2 25
$-0.06
Q1 25
$-0.16
Q4 24
$0.10
Q3 24
$0.07
Q2 24
$0.10
Q1 24
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVR
CVR
SRTS
SRTS
Cash + ST InvestmentsLiquidity on hand
$1.7M
$22.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$18.8M
$48.1M
Total Assets
$23.3M
$53.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVR
CVR
SRTS
SRTS
Q4 25
$1.7M
$22.1M
Q3 25
$1.7M
$24.5M
Q2 25
$1.2M
$22.2M
Q1 25
$765.6K
$19.1M
Q4 24
$2.2M
$22.1M
Q3 24
$2.2M
$22.6M
Q2 24
$2.6M
$19.0M
Q1 24
$2.7M
$14.7M
Total Debt
CVR
CVR
SRTS
SRTS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CVR
CVR
SRTS
SRTS
Q4 25
$18.8M
$48.1M
Q3 25
$20.0M
$51.2M
Q2 25
$20.0M
$52.1M
Q1 25
$20.4M
$53.0M
Q4 24
$20.0M
$55.8M
Q3 24
$23.7M
$54.1M
Q2 24
$25.2M
$52.9M
Q1 24
$25.2M
$51.2M
Total Assets
CVR
CVR
SRTS
SRTS
Q4 25
$23.3M
$53.0M
Q3 25
$24.0M
$58.3M
Q2 25
$23.6M
$58.9M
Q1 25
$24.1M
$60.2M
Q4 24
$23.4M
$62.2M
Q3 24
$26.4M
$59.9M
Q2 24
$27.3M
$58.2M
Q1 24
$27.8M
$57.3M
Debt / Equity
CVR
CVR
SRTS
SRTS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVR
CVR
SRTS
SRTS
Operating Cash FlowLast quarter
$116.4K
$-2.2M
Free Cash FlowOCF − Capex
$24.3K
$-2.4M
FCF MarginFCF / Revenue
0.4%
-47.9%
Capex IntensityCapex / Revenue
1.5%
3.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-1.6M
$332.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVR
CVR
SRTS
SRTS
Q4 25
$116.4K
$-2.2M
Q3 25
$638.0K
$2.3M
Q2 25
$28.2K
$3.1M
Q1 25
$-2.0M
$-2.7M
Q4 24
$-60.1K
$-827.0K
Q3 24
$-58.2K
$4.0M
Q2 24
$363.5K
$4.2M
Q1 24
$-398.8K
$-8.2M
Free Cash Flow
CVR
CVR
SRTS
SRTS
Q4 25
$24.3K
$-2.4M
Q3 25
$492.1K
$2.3M
Q2 25
$-22.8K
$3.1M
Q1 25
$-2.1M
$-2.7M
Q4 24
$-118.1K
$-1.1M
Q3 24
$-368.9K
$3.6M
Q2 24
$58.0K
$4.2M
Q1 24
$-491.8K
$-8.4M
FCF Margin
CVR
CVR
SRTS
SRTS
Q4 25
0.4%
-47.9%
Q3 25
6.7%
33.3%
Q2 25
-0.3%
42.2%
Q1 25
-28.3%
-32.2%
Q4 24
-2.9%
-8.6%
Q3 24
-5.3%
40.9%
Q2 24
0.7%
45.8%
Q1 24
-6.3%
-79.0%
Capex Intensity
CVR
CVR
SRTS
SRTS
Q4 25
1.5%
3.2%
Q3 25
2.0%
0.1%
Q2 25
0.7%
0.4%
Q1 25
0.6%
0.1%
Q4 24
1.4%
2.3%
Q3 24
4.5%
3.8%
Q2 24
3.8%
0.0%
Q1 24
1.2%
2.2%
Cash Conversion
CVR
CVR
SRTS
SRTS
Q4 25
Q3 25
9.44×
Q2 25
Q1 25
-5.01×
Q4 24
-0.53×
Q3 24
3.25×
Q2 24
2.56×
2.62×
Q1 24
-3.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVR
CVR

Fastener$5.1M85%
Other$890.7K15%

SRTS
SRTS

Products$2.8M57%
Other$2.1M43%

Related Comparisons